Requiring fresh tumor biopsies adds complexity. How do we ensure sample viability during transport, and what if delays occur in getting results within the promised 72 hours?

Requiring fresh tumor biopsies does introduce logistical complexity, but Elephas has established a validated cold-chain workflow to ensure sample integrity. Core-needle biopsies are immediately placed in Elephas Transport Media within a temperature-controlled kit and shipped overnight to our CLIA-certified lab. Upon arrival, samples undergo viability and composition QC before being embedded in the elive Gel, which maintains the live tumor�immune architecture for ex vivo treatment and analysis.